abrdn Healthcare Investors $HQH Shares Purchased by Samalin Investment Counsel LLC

Samalin Investment Counsel LLC boosted its position in shares of abrdn Healthcare Investors (NYSE:HQH) by 9.7% in the second quarter, HoldingsChannel.com reports. The fund owned 87,850 shares of the financial services provider’s stock after purchasing an additional 7,802 shares during the period. Samalin Investment Counsel LLC’s holdings in abrdn Healthcare Investors were worth $1,361,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Costello Asset Management INC purchased a new stake in abrdn Healthcare Investors during the first quarter worth about $40,000. US Bancorp DE grew its holdings in shares of abrdn Healthcare Investors by 192.8% in the first quarter. US Bancorp DE now owns 3,733 shares of the financial services provider’s stock valued at $61,000 after purchasing an additional 2,458 shares in the last quarter. Ameritas Advisory Services LLC acquired a new position in shares of abrdn Healthcare Investors in the second quarter valued at approximately $96,000. Allworth Financial LP increased its stake in abrdn Healthcare Investors by 53,894.1% during the 2nd quarter. Allworth Financial LP now owns 9,179 shares of the financial services provider’s stock worth $142,000 after buying an additional 9,162 shares during the period. Finally, Integrated Wealth Concepts LLC acquired a new stake in abrdn Healthcare Investors during the 1st quarter worth approximately $166,000. 32.60% of the stock is owned by institutional investors and hedge funds.

abrdn Healthcare Investors Price Performance

Shares of HQH stock opened at $17.76 on Monday. abrdn Healthcare Investors has a 52 week low of $13.77 and a 52 week high of $19.69. The firm has a 50 day moving average of $18.00 and a two-hundred day moving average of $16.58.

abrdn Healthcare Investors Profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.